Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Urol Oncol. 2016 Jan 12;34(5):239.e1–239.e8. doi: 10.1016/j.urolonc.2015.12.001

Table 4a.

Multivariable Cox model for cancer-specific and overall survival after 9 months after diagnosis

Cancer-specific survival Overall survival
HR 95% CI p value HR 95% CI p value
SWT (per mo) 0.94 0.80–1.11 0.5 1.17 1.08–1.27 0.0002
Gender
 Female Ref. 0.004 Ref. 0.2
 Male 2.14 1.28–3.56 1.21 0.91–1.62
Race
 White Ref. 0.4 Ref. >0.9
 Non-white 1.36 0.65–2.85 0.99 0.59–1.65
Age (per 5 yr) 1.02 1.00–1.04 0.013 1.05 1.04–1.07 <0.0001
CCI
 0 Ref. 0.5 Ref. 0.5
 ≥ 1 1.16 0.72–1.88 1.11 0.80–1.53
BMI 1.01 0.97–1.04 0.8 1.00 0.97–1.02 0.8
Presentation
 Incidental Ref <0.0001 Ref. 0.002
 Local 2.17 1.40–3.35 1.21 0.91–1.61
 Systemic 4.37 2.35–8.10 2.25 1.43–3.54
Tumor Size (per cm) 1.12 1.06–1.18 <0.0001 1.10 1.06–1.15 <0.0001
Tumor Histology
 Non-clear cell Ref. 0.003 Ref. 0.009
 Clear cell 2.33 1.34–4.07 1.52 1.11–2.08

HR = hazard ratio; CI = confidence interval; SWT = surgical waiting time; Ref = reference value; CCI = Charlson Comorbidity Index; BMI = body mass index.